FAH President and CEO Chip Kahn released the following statement in reaction to the release of Speaker Nancy Pelosi’s plan to lower the price of prescription drugs: “Skyrocketing drug costs are causing a crisis for […]
Read More… from FAH Appreciates Congress Addressing Rising Drug Costs
Continued rising drug prices, as well as shortages for many critical medications, are impacting patient care and putting strains on hospital budgets and operations. That’s why hospitals and health systems have gathered to create Civica Rx, a not-for-profit generic drug company that is disrupting the pharmaceutical market. Chip spoke with Martin VanTrieste, Civica’s President & CEO, about why and how the company was formed, the success it is enjoying so far, and if other drug companies will follow its lead. […]
Read More… from Disrupting the Drug Market With Martin Van Trieste
